Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
about
Shear stress modulation of IL-1β-induced E-selectin expression in human endothelial cellsThe Renin-Angiotensin-aldosterone system in vascular inflammation and remodelingTherapeutic modulation of the natural history of coronary atherosclerosis: lessons learned from serial imaging studiesAerobic Exercise and Pharmacological Therapies for Skeletal Myopathy in Heart Failure: Similarities and DifferencesAngiotensin-(1-7): new perspectives in atherosclerosis treatmentUsing advanced noninvasive imaging techniques to probe the links between regional coronary artery endothelial dysfunction and atherosclerosisThe role of transforming growth factor β1 in the regulation of blood pressureAutonomic nervous system and immune system interactionsCardiac remodelling and RAS inhibitionEmerging risk biomarkers in cardiovascular diseases and disordersCardiac defects contribute to the pathology of spinal muscular atrophy modelsA system-level investigation into the mechanisms of Chinese Traditional Medicine: Compound Danshen Formula for cardiovascular disease treatmentMechanism of Ang II involvement in activation of NF-κB through phosphorylation of p65 during agingEffects of aliskiren on stroke in rats expressing human renin and angiotensinogen genesImpaired regulation of cardiac function in sepsis, SIRS, and MODS.Suppressive effects of irbesartan on inflammation and apoptosis in atherosclerotic plaques of apoE-/- mice: molecular imaging with 14C-FDG and 99mTc-annexin A5.The role of aldosterone in mediating the dependence of angiotensin hypertension on IL-6.Are "functionally related polymorphisms" of renin-angiotensin-aldosterone system gene polymorphisms associated with hypertension?Combination therapy with an angiotensin-converting-enzyme inhibitor and an angiotensin II receptor antagonist ameliorates microinflammation and oxidative stress in patients with diabetic nephropathy.A current view of brain renin-angiotensin system: Is the (pro)renin receptor the missing link?The attenuation of platelet and monocyte activation in a rabbit model of extracorporeal circulation by a nitric oxide releasing polymer.The influence of heart failure self-care on health outcomes: hypothetical cardioprotective mechanisms.Sensitivity of NOS-dependent vascular relaxation pathway to mineralocorticoid receptor blockade in caveolin-1-deficient mice.Interactions between adrenal-regulatory and calcium-regulatory hormones in human health.Brain microglial cytokines in neurogenic hypertensionThe past, present and future of renin-angiotensin aldosterone system inhibitionHDAC inhibition attenuates inflammatory, hypertrophic, and hypertensive responses in spontaneously hypertensive rats.Role of the renin-angiotensin system in the pathogenesis of intimal hyperplasia: therapeutic potential for prevention of vein graft failure?Evaluation of Toll-Like receptor 2 and 4 RNA expression and the cytokine profile in postmenopausal women with metabolic syndrome.Chemoprevention of esophageal adenocarcinomaDiscovery of Potential Inhibitors of Aldosterone Synthase from Chinese Herbs Using Pharmacophore Modeling, Molecular Docking, and Molecular Dynamics Simulation Studies.Mineralocorticoid receptors in vascular disease: connecting molecular pathways to clinical implications.Krüppel-like factor 4 transcriptionally regulates TGF-β1 and contributes to cardiac myofibroblast differentiation.Role of mineralocorticoid receptor antagonists in cardiovascular disease.Association between angiotensin-converting enzyme inhibitors and troponin in acute coronary syndrome.Relationship between chronic kidney disease and risk of coronary heart disease in Korean menAldosterone, parathyroid hormone, and the use of renin-angiotensin-aldosterone system inhibitors: the multi-ethnic study of atherosclerosisOlmesartan vs. ramipril in elderly hypertensive patients: review of data from two published randomized, double-blind studies.Proinflammatory protein CARD9 is essential for infiltration of monocytic fibroblast precursors and cardiac fibrosis caused by Angiotensin II infusion.Telmisartan activates endothelial nitric oxide synthase via Ser1177 phosphorylation in vascular endothelial cells
P2860
Q21134771-BD115523-895F-4010-A698-A1440CEB85CCQ21284671-48B097F9-12B2-4692-8762-090AFDB64661Q26738588-5AAE1484-7C1B-4959-B23A-9C40CF1D111DQ26767412-ADB339C6-DECA-47B9-9026-947B71628413Q26770846-91DB70C7-4F9B-4F67-9D4A-D99CE73CAC9FQ26829688-C147C3A0-A52D-4153-8B50-AEA09FA0988CQ26998564-0E37803F-CF57-4C62-AEE5-A3F5DF2D5D5FQ27026889-357FFC17-DE2D-477F-9039-DF5B8E41AD36Q28076749-1DC4E0C7-F3E4-4BF1-A0E5-4F5A45240C16Q28081614-7F93B949-1011-4139-A603-326EAE95733CQ28290032-189C1521-32B5-41BD-8777-AEAD4C606A55Q28483412-51A4BEEF-5995-4893-91BD-91FF45E2A33AQ28578917-942D85CA-1150-4554-B4DC-4E6358530B9BQ28744563-B7FEBA36-7F7C-4999-8AAD-565F5E9CDA05Q30319125-91416F58-7EA1-4B1F-A6BC-DDFF532F1FFDQ31152104-548D5700-03D6-49FC-9C3A-26F4BCA80ADFQ33579257-906FC4B3-263A-4AC5-8EA1-F91F98A29EF9Q33594915-645F28D1-B2DC-4645-9F52-E4144EFFA855Q33603422-713652A8-D4E2-4DFE-BD48-80F8A38A147EQ33625889-D5E4C990-DA48-42BD-8E63-A910F6B5C545Q33648166-672ABE5B-4218-4031-BF02-53AC333B035DQ33897455-752CE7B1-0B76-4246-896B-67CFEA84B0AAQ33917152-7F4D3C48-E809-45D7-AF33-40F2DF0B1817Q34008136-D4ADBC98-1C3E-452F-82BF-5EC6C654382BQ34089804-CE1893E8-BDD3-48CC-A3EF-C6F18A66F5F9Q34094354-763489D6-E3F0-4403-BF93-1ED5D4B5F0F3Q34099442-F4AC84D0-D24C-48F2-8C33-232F8EAA089EQ34306932-ED445CE8-FC18-433B-90D0-C3F882B9F0EAQ34361828-92B0C775-D1C9-418E-AAAC-47A1AC2BE1BBQ34408890-F4C75F52-3A32-4499-9B2C-48D9605C8DF3Q34543422-FC022789-AB4B-4D70-8064-C3A4C61E1B66Q34684861-C0CD46CC-585F-4990-835F-C1B677C71CBCQ34707131-9A9D5815-08EC-4315-ADB0-3DF9F9009072Q34817129-BBF66D84-F6B0-4A47-BEE4-B3F42C4E4AB8Q34914616-84BC332A-8F99-429D-91CA-E4E75479C7B7Q35009842-ECC4487F-B4E4-415D-9CF7-701C84831F51Q35055052-D1F618D4-5884-4886-B264-6DA0F3647B95Q35085669-ED8AF250-94A1-4548-B62F-BCACED85CF19Q35114753-79BA8240-0C51-49ED-9B34-256EF3AC7B29Q35168375-CCDDFFEF-85A4-48EE-A859-22AF52069542
P2860
Role of the renin-angiotensin-aldosterone system and proinflammatory mediators in cardiovascular disease.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Role of the renin-angiotensin- ...... ors in cardiovascular disease.
@ast
Role of the renin-angiotensin- ...... ors in cardiovascular disease.
@en
type
label
Role of the renin-angiotensin- ...... ors in cardiovascular disease.
@ast
Role of the renin-angiotensin- ...... ors in cardiovascular disease.
@en
prefLabel
Role of the renin-angiotensin- ...... ors in cardiovascular disease.
@ast
Role of the renin-angiotensin- ...... ors in cardiovascular disease.
@en
P1476
Role of the renin-angiotensin- ...... ors in cardiovascular disease.
@en
P2093
Carlos M Ferrario
William B Strawn
P304
P356
10.1016/J.AMJCARD.2006.01.059
P407
P577
2006-05-09T00:00:00Z